We observed that the silencing of HNF1A-AS1 in lung adenocarcinoma cells dramatically blocked tumor growth and metastasis in vivo and in vitro, raising the possibility that HNF1A-AS1 could be a promising new therapeutic target for highly aggressive lung adenocarcinoma. Here, HNF1A is linked to lung adenocarcinoma.